Chemical and Drug Induced Liver Injury: all 80 studies
Page 1 of 1. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- Silymarin Versus N-Acetylcysteine as Protective Effect Against Anti-tuberculosis Drugs Induced Liver Injury.Not yet recruitingNCT07875322Early Phase 1
- Misocholic Tablets for Non-Viral Elevated Liver EnzymesNot yet recruitingNCT07833514Phase 3
- Prevalence and Prognosis of Drug-Induced Liver InjuryNot yet recruitingNCT07830901
- A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological DiseasesNot yet recruitingNCT07476885
- Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and PredictorsNot yet recruitingNCT07472348
- Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , KarachiNot yet recruitingNCT07058090Phase 1
- Glucocorticoids for Acute Drug Induced Liver Injury With HyperbilirubinemiaRecruitingNCT06922669Not applicable
- Prospective Cohort of Immune Checkpoint Inhibitor-induced HepatitisRecruitingNCT06864481
- Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver DiseaseNot yet recruitingNCT06797011Phase 2/3
- Prospective Comparative Validation Study of RUCAM and RECAMRecruitingNCT06771011
- Drug-induced Liver Injury: Itching StudyRecruitingNCT06446609
- Livertoxcicity in Acute Leukemia Patients During Chemotherapy TreatmentNot yet recruitingNCT06383325
- SAMe in Prevention of Oxaliplatin-associated Liver InjuryNot yet recruitingNCT06258525Phase 2
- A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI SubjectsRecruitingNCT06019936Phase 2
- Alterations of Gut Microbiota and Serum Biochemical Markers in DILI PatientsRecruitingNCT05465642
- A Prognostic Model for Drug-induced Liver Injury in ChinaRecruitingNCT05060289
- Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control StudyRecruitingNCT04964310
- Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related HepatitisRecruitingNCT04810156Phase 2
- Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control TrialRecruitingNCT04553003Phase 4
- A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)RecruitingNCT02961413
- Drug-Induced Liver Injury (DILI) Network RetrospectiveRecruitingNCT00360646
- Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug InteractionsCompletedNCT06192589Phase 1Results posted
- Digoxin In Treatment of Alcohol Associated HepatitisTerminatedNCT05014087Phase 2Results posted
- Ultrasound Method to Measure Fibrosis of the Liver in ChildrenTerminatedNCT02086708Not applicableResults posted
- Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
- Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver InjuryCompletedNCT01548690Phase 2Results posted
- Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive DaysCompletedNCT00616018Phase 4Results posted
- Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver FailureActive, not recruitingNCT06872372Not applicable
- A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic AgentsActive, not recruitingNCT06670391
- Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver InjuryActive, not recruitingNCT06547229
- Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis DrugsActive, not recruitingNCT06539455
- miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 TrialCompletedNCT06285253Phase 1
- Remaxol® in Patients With Drug-induced Liver Injuries During Cancer ChemotherapyCompletedNCT05789797
- Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled TrialStatus unknownNCT05738681Phase 2/3
- Bicyclol in the Treatment of Antineoplastic Drug-induced Liver Injury.Status unknownNCT05711459Not applicable
- Discrimination of DILI and AIH by Artificial IntelligenceCompletedNCT05532345
- Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen OverdoseTerminatedNCT05517668Phase 2
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to PlaceboCompletedNCT05144217Phase 2/3
- The Multi-Center, Randomized, Double-blind, Positive Controlled Clinical Trial of Bicyclol in the Treatment of Acute DILIStatus unknownNCT05063500Phase 3
- Combi-elastography Assessment of Chronic Liver Disease Multi-center StudyStatus unknownNCT04625166
- Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver InjuryCompletedNCT04595916Phase 4
- A Diagnostic Study on Patients With Drug-induced Liver InjuryStatus unknownNCT04526548
- Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver InjuryStatus unknownNCT04302506
- A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient SettingTerminatedNCT04269486
- Hepatotoxicity of Antituberculosis Therapy (HAT) StudyStatus unknownNCT04159441
- Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol OverdoseCompletedNCT03679442Phase 1
- Liver Function After Intravenous Methylprednisolone AdministrationCompletedNCT03667157Phase 4
- A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism StatusCompletedNCT03665402Not applicable
- Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral DrugsCompletedNCT03602703
- 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILICompletedNCT03266146Phase 1/2
- Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis PatientsCompletedNCT03211208
- Surveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.Status unknownNCT03113838
- Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous MeningitisCompletedNCT03100786Phase 3
- Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)CompletedNCT03092817Phase 3
- Surveillance for Early Liver Injuries Caused by Xianlin Gubao GranuleStatus unknownNCT03091608
- Surveillance for Early Liver Injuries Caused by Xianlin Gubao Pill.Status unknownNCT03091556
- Surveillance for Early Liver Injuries Caused by Xianlin Gubao Capsule.Status unknownNCT03091244
- Surveillance for Early Liver Injuries Caused by Runzao Zhiyang Capsule.Status unknownNCT03091218
- Clarify of Predictive Risk Factors of Chemotherapy-induced Liver InjuryStatus unknownNCT03069820Phase 4
- Surveillance for Early Liver Injuries Caused by Zhuanggu Guanjie PillStatus unknownNCT03060252
- Comparative Study of Circulating microRNA Changes in Patients With Liver Injury and Healthy SubjectsStatus unknownNCT03000621
- The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILICompletedNCT02944552Phase 2
- Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver InjuryCompletedNCT02734966Phase 2
- Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver InjuryTerminatedNCT02686385Not applicable
- Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILICompletedNCT02651350Phase 1/2
- A Retrospective Study on Drug Induced Liver Injury in ChinaCompletedNCT02407964
- Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and HepatotoxicityStatus unknownNCT02353455
- Liver Enzyme Abnormalities and Risk Factors in Taking Herbal MedicineCompletedNCT02299739
- A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced HepatitisCompletedNCT02182167Phase 2/3
- A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI)CompletedNCT02143323Phase 1
- Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)Status unknownNCT02061826
- The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis DrugsCompletedNCT01800487Not applicable
- Preliminary Evaluation of a Point-Of-Care Liver Function TestCompletedNCT01705041Not applicable
- Rechallenge, Potential Drug Induced Liver Injury (Kaiser)CompletedNCT01584765
- Risk of Acute Liver Injury in Users of AntimicrobialsCompletedNCT01434173
- Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)CompletedNCT01231022
- Cholestatic Drug-induced Liver InjuryStatus unknownNCT01141322Phase 4
- Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating FeverWithdrawnNCT01137591Not applicable
- Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver InjuryCompletedNCT01000766
- Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver DamageCompletedNCT00405301Phase 4